194 related articles for article (PubMed ID: 20949564)
1. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response.
Gougelet A; Pissaloux D; Besse A; Perez J; Duc A; Dutour A; Blay JY; Alberti L
Int J Cancer; 2011 Aug; 129(3):680-90. PubMed ID: 20949564
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
Bruheim S; Xi Y; Ju J; Fodstad O
Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
[TBL] [Abstract][Full Text] [Related]
3. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
[TBL] [Abstract][Full Text] [Related]
4. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
Xiao F; Chen J; Lian C; Han P; Zhang C
Mol Med Rep; 2015 Jan; 11(1):739-45. PubMed ID: 25335093
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.
Won KY; Kim YW; Kim HS; Lee SK; Jung WW; Park YK
Hum Pathol; 2013 Aug; 44(8):1648-55. PubMed ID: 23574781
[TBL] [Abstract][Full Text] [Related]
7. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
[TBL] [Abstract][Full Text] [Related]
8. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
10. miR-181c associates with tumor relapse of high grade osteosarcoma.
Mori F; Sacconi A; Canu V; Ganci F; Novello M; Anelli V; Covello R; Ferraresi V; Muti P; Biagini R; Blandino G; Strano S
Oncotarget; 2015 Jun; 6(16):13946-61. PubMed ID: 26062442
[TBL] [Abstract][Full Text] [Related]
11. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.
Novello C; Pazzaglia L; Cingolani C; Conti A; Quattrini I; Manara MC; Tognon M; Picci P; Benassi MS
Int J Oncol; 2013 Feb; 42(2):667-75. PubMed ID: 23229283
[TBL] [Abstract][Full Text] [Related]
13. [Cloning and identification of microRNA from human osteosarcoma cell line SOSP-9607].
Gao J; Yang TT; Qiu XC; Yu B; Han JW; Fan QY; Ma BA
Ai Zheng; 2007 Jun; 26(6):561-5. PubMed ID: 17562257
[TBL] [Abstract][Full Text] [Related]
14. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
Sun B; Yang M; Li M; Wang F
Biomed Pharmacother; 2015 Apr; 71():58-63. PubMed ID: 25960216
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
16. miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis.
Song YD; Li DD; Guan Y; Wang YL; Zheng J
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):75-79. PubMed ID: 28980925
[TBL] [Abstract][Full Text] [Related]
17. miRNA signatures associate with pathogenesis and progression of osteosarcoma.
Jones KB; Salah Z; Del Mare S; Galasso M; Gaudio E; Nuovo GJ; Lovat F; LeBlanc K; Palatini J; Randall RL; Volinia S; Stein GS; Croce CM; Lian JB; Aqeilan RI
Cancer Res; 2012 Apr; 72(7):1865-77. PubMed ID: 22350417
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
19. miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors.
Jacques C; Calleja LR; Baud'huin M; Quillard T; Heymann D; Lamoureux F; Ory B
Oncotarget; 2016 Aug; 7(34):54503-54514. PubMed ID: 27486986
[TBL] [Abstract][Full Text] [Related]
20. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation.
Xu J; Yao Q; Hou Y; Xu M; Liu S; Yang L; Zhang L; Xu H
Biomed Pharmacother; 2013 Jun; 67(5):381-6. PubMed ID: 23601845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
